FDA Presses Pause on Trial for OTC Version of Anti-impotence Drug Cialis
The US health regulator has put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter treatment, French drugmaker Sanofi said on Monday.
Reuters Health Information
source https://www.medscape.com/viewarticle/974787?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/974787?src=rss
Comments
Post a Comment